Health Research Consent Declaration Committee (HRCDC) annual activities report 2019
The HRCDC plays an important role in the new regulatory landscape for health research as a result of the landmark General Data Protection Regulations (GDPR) and subsequent Health Research Regulations (Regulations).
Health Research Consent Declaration Committee
core
Ethics Eye නිරීක්ෂකයෙකු වන්න ඔබටත් පුළුවන්!
This entry includes only three infographics (in Sinhala) and no writeups.On January 8, 2024, the Ethics Eye team published a three-slide post on their facebook page encouraging followers and others to join the team as external media ethics violation ...
Ethics Eye
core +1 more source
Do we really know how many clinical trials are conducted ethically? Why research ethics committee review practices need to be strengthened and initial steps we could take to strengthen them. [PDF]
Yarborough M.
europepmc +1 more source
Added Prognostic Value of EEG Reactivity in Comatose Patients Following Cardiac Arrest
ABSTRACT Objectives To evaluate the added prognostic value of EEG reactivity for favorable outcome compared with background analysis during and after targeted temperature management (TTM). Methods Prospective observational cohort study of comatose post–cardiac arrest patients admitted to a single academic center between 2017 and 2022, all undergoing ...
Sarah Caroyer +11 more
wiley +1 more source
A Qualitative Study on Experiences and Perspectives of Members of a Dutch Medical Research Ethics Committee. [PDF]
Janssens RMJPA +5 more
europepmc +1 more source
ABSTRACT Objectives Acute kidney injury (AKI) is a common but often underrecognized complication in ischemic stroke patients undergoing mechanical thrombectomy, particularly among those with pre‐existing renal impairment. This study evaluated the incidence, risk factors, and clinical impact of AKI in this high‐risk population.
Michał Borończyk +10 more
wiley +1 more source
Strengthening Research Ethics Committee Capacity: A Focused PubMed-Based Review with Implications for Maternity Hospitals [PDF]
Xuenan Zhang +2 more
openalex +1 more source
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Views of research ethics committee members on end-of-participation communications for trial participants who stop taking part: a cross-sectional survey study. [PDF]
Cragg WJ +5 more
europepmc +2 more sources
Risk Assessment of Medical Study Procedures in the Documents Submitted to a Research Ethics Committee. [PDF]
Happo S +3 more
europepmc +1 more source

